Buprenorphine Test

The MMC Buprenorphine Test offers a professional-grade solution for the presumptive identification of Buprenorphine in various forms. As a potent opioid, doctors primarily prescribe buprenorphine to treat opioid use disorder, as well as acute and chronic pain. Because this substance frequently appears in diverted pharmaceutical markets—including sublingual tablets, cheek films, injections, and skin patches—investigators require a reliable field tool for immediate identification. 

This specialised test reacts specifically to the chemical structure of buprenorphine. Whether the sample is a crushed tablet, a liquid residue, or a dissolved film, the test provides a clear visual reaction within seconds. This allows law enforcement, customs officials, and forensic experts to distinguish between controlled medications and other non-regulated materials. By identifying these compounds on-site, teams can make informed decisions without waiting for long laboratory lead times. 

Unlike traditional narcotic tests that rely on hazardous liquid acids, the MMC design prioritises user safety. These kits contain minimal liquid reagents and require no acid neutralisers. This modern technology eliminates many risks associated with chemical burns or environmental contamination. Consequently, investigators can perform tests in diverse environments—from roadside stops to indoor scenes—with total confidence and minimal protective gear.

While this kit serves as a reliable first-line screening solution, it remains a presumptive tool. Therefore, a positive result should always lead to confirmatory laboratory methods like GC/MS or LC/MS. This process ensures compliance with professional regulatory standards while maintaining a practical workflow for high-volume screening. Each pack contains 10 individual tests, providing a cost-effective solution for routine field inspections.